Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gaurav, Ganeshwala"'
Autor:
Balbir, Singh, Paresh, Pai, Harish, Kumar, Sheeba, George, Sandeep, Mahapatra, Vineet, Garg, G N, Gupta, Kiran, Makineni, Gaurav, Ganeshwala, Pravin, Narkhede, Syed M H, Naqvi, Kumar, Gaurav, Mohammed Y K, Hukkeri
Publikováno v:
Cardiology and Therapy. 11:49-79
Non-vitamin K antagonist oral anticoagulants (NOACs) are a new class of anticoagulant drugs used in the prevention and treatment of venous thromboembolism (VTE) and atrial fibrillation (AF). Anticoagulation requires the integration of the correct typ
Autor:
Shirish Hiremath, Gaurav Ganeshwala
Publikováno v:
Cardiodiabetes Update: A Textbook of Cardiology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47f3aac6ffcc504b04f7581d73824e03
https://doi.org/10.5005/jp/books/14130_117
https://doi.org/10.5005/jp/books/14130_117
Autor:
Krishna Upas Natarajan, Jignesh M Parikh, Gaurav Ganeshwala, Anil Venkitachalam, Navin Mathew
Publikováno v:
Neurology India. 67:1528
Arrhythmogenic right ventricular dysplasia (ARVD) is an underdiagnosed cardiomyopathy which commonly presents in young adults with ventricular tachycardia or sudden cardiac death. We report a case of ARVD presenting with features of acute ischemic ce
Publikováno v:
Journal of Medical Toxicology. 6:27-30
Pyrethroids are common household insecticides. Even though they are less toxic to humans, reports of accidental and suicidal poisoning are not uncommon. Cardiotoxicity due to pyrethroid poisoning is rare. We report a case of cardiac conduction distur
Autor:
Parvin Kumar Goel, P C Rath, Viveka Kumar, A George Koshy, Upendra Kaul, Anil K. Mishra, Mathew Samuel Kalarickal, Gaurav Ganeshwala, A.U. Mahajan, Praveen Chandra, G.S. Wander, Manjunath Cholenahally Nanjappa, Ashok Seth, Ajitkumar Velaparambil Kumaran, Vinay K. Bahl, Vijay Trehan
Publikováno v:
Journal of the American College of Cardiology. 69:S31
MeRes100 (Meril Life Science, Gujarat, India) is a novel Sirolimus-eluting BioResorbable Vascular Scaffold System (BRS). This sub study of MeRes-1 trial evaluated the systemic release of sirolimus from the MeRes100 BRS applied for the treatment of de
Autor:
P C Rath, Ashok Seth, Vijay Trehan, Viveka Kumar, Vinay K. Bahl, Praveen Chandra, G.S. Wander, Mathew Samuel Kalarickal, Upendra Kaul, Anil K. Mishra, A George Koshy, Gaurav Ganeshwala, Manjunath Cholenahally Nanjappa, A.U. Mahajan, Parvin Kumar Goel, Ajitkumar Velaparambil Kumaran
Publikováno v:
Journal of the American College of Cardiology. 69:S2
The life-long presence of the metallic prosthesis interferes with the restoration of vasomotion and restricts quality lesion imaging during repeat surgical or percutaneous treatment. As a solution to this, we assessed safety and efficacy of a novel P
Autor:
Ashok Seth, Praveen Chandra, Vinay Kumar Bahl, Manjunath Cholenahally Nanjappa, Pratap Chandra Rath, Mathew Samuel Kalarickal, Gurpreet Singh Wander, Anil Mishra, Ajaykumar Umakant Mahajan, Ajit Kumar Velaparambil Kumaran, AGeorge Koshy, Parvin Kumar Goel, Gaurav Ganeshwala, Viveka Kumar, Upendra Kaul, Vijay Kumar
Publikováno v:
JACC: Cardiovascular Interventions. 10:S57
MeRes100 (Meril Life Science, Vapi, India) is a novel Sirolimus-Eluting BioResorbable Vascular Scaffold system (BRS). This sub study of MeRes-1 trial evaluated the systemic release of sirolimus from the MeRes100 BRS applied for the treatment of de no
Publikováno v:
The American Journal of Emergency Medicine. 31:1157.e1-1157.e3
A 62-year-old male smoker with no other comorbidities presented to emergency department with systemic anaphylaxis, due to oral diclofenac for toothache. He developed acute anterior wall myocardial infarction following IM epinephrine 1 mg 1:1000. Prim